Are men who have sex with men in Europe protected from hepatitis B?

Abstract

Hepatitis B vaccination is recommended for men who have sex with men (MSM) in many countries, but information on vaccine coverage is scarce. We studied hepatitis B vaccination programmes and coverage among MSM in Europe to guide prevention. From a large (N = 174 209) pan-European MSM survey (EMIS-2010), we used data on self-reported hepatitis B vaccination, age, education, settlement size and disclosure of the same-sex sexual orientation (‘outness’). We excluded participants with a history of hepatitis B. In multilevel (participants, countries) logistic regression models, we calculated adjusted odds ratios (aOR) with 95% confidence intervals (95% CI). We analysed data of 163 987 MSM in 38 European countries: 38.3% were ‘out’ to all or almost all, 56.4% reported vaccination against hepatitis B and 65.5% lived in countries with free recommended hepatitis B vaccination for MSM. In the final model the odds for being vaccinated increased with outness (‘out to all or almost all’: aOR 1.76, 95% CI 1.70–1.83 vs. ‘out to no one’) and with living in countries, where hepatitis B vaccination was recommended and free-of-charge for MSM (aOR 2.21, 95% CI 1.47–3.32 vs. ‘no or unclear recommendation’). To increase hepatitis B vaccination coverage among MSM, implementation of MSM-specific recommendations and improvement of the societal climate for MSM is needed.

Hepatitis B Vaccination Coverage in Germany: Systematic Review

“…In this study, vaccination uptake was higher in MSM who were affected by universal vaccination recommendations, as well as in MSM who were affected by speci c vaccination recommendations. This matched the result that being "out" was correlated with being vaccinated in older MSM, but not in younger MSM, who were covered by the universal childhood immunisation (20).…”

“…Three studies were related to MSM. One of them reported on an internet-based survey showing complete VC of 52.3% (20). The two other studies were conducted among HIV-positive MSM (see above) with a VC between 47.1% and 47.7% (28,49).…”

Epidemiologie der Virushepatitiden A bis E in Deutschland

“…sogar unter 60%, wie z.B. bei MSM [18,19]. Für die Therapie der HBV stehen abhängig vom Stadium der Erkrankung wirksame Therapieoptionen zur Verfügung, welche die Viruslast sen-ken und Spätfolgen verhindern können [20].…”

Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens

“…Die „Abdeckung der Opioidsubstitution bei PWID“ (A.24) wurde für das Jahr 2016 für Deutschland aus den Daten des Substitutionsregisters (Zähler; jährlich publiziert [ 46 ]) und der für 2016 publizierten Anzahl von Opioidabhängigen in Deutschland (Nenner) generiert [ 47 ]. MSM sind in Daten aus dem European MSM Internetsurvey (EMIS) abgebildet [ 48 ]. Da es sich um eine wiederkehrende Querschnittsbefragung handelt, stehen sowohl Daten aus der Basis- als auch aus den nachfolgenden Befragungen zur Verfügung.…”